Inflammatory Bowel Disease Provoked by Etanercept: Report of 443 Possible Cases Combined from an IBD Referral Center and the FDA

Manifestation of Crohn's disease in a young woman during the course of treatment for severe form of chronic plaque psoriasis with etanercept

(2014) Martin Tichy et al.   Dermatologic Therapy

Etanercept – TNF receptor and IgG1 Fc fusion protein: is it different from other TNF blockers?

(2014) Hubert Marotte et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Assessing the likelihood of new-onset inflammatory bowel disease following tumor necrosis factor-alpha inhibitor therapy for rheumatoid arthritis and juvenile rheumatoid arthritis

(2014) Asha Krishnan et al.   RHEUMATOLOGY INTERNATIONAL

Development of inflammatory bowel disease during anti-TNF-α therapy for inflammatory rheumatic disease. A nationwide series

(2011) Éric Toussirot et al.   JOINT BONE SPINE

Characterization of patients with infliximab-induced lupus erythematosus and outcomes after retreatment with a second anti-TNF agent

(2010) Sreedhar Subramanian et al.   INFLAMMATORY BOWEL DISEASES

Paradoxical adverse events of anti-tumour necrosis factor therapy for spondyloarthropathies: a retrospective study

(2009) D. Fouache et al.   RHEUMATOLOGY

Crohn’s disease during etanercept therapy in juvenile idiopathic arthritis: a case report and review of the literature

(2009) V. Wiegering et al.   RHEUMATOLOGY INTERNATIONAL

Autoimmune disease concomitance among inflammatory bowel disease patients in the United States, 2001-2002

(2008) Russell Cohen et al.   INFLAMMATORY BOWEL DISEASES

Emergence of Crohn's Disease During Treatment with the Anti-Tumor Necrosis Factor Agent Etanercept for Ankylosing Spondylitis: Possible Mechanisms of Action

(2008) Boulos Haraoui et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM